Surfacing hard-to-identify patients

The challenge of underdiagnoses when launching a rare disease drug There are 7,000 known rare diseases and 95 percent of them do not have any FDA-approved therapeutic. However, with greater [...]

2021-04-15T10:01:05-08:00April 15th, 2021|